Itraconazole for Fungal Sensitive Chronic Rhinosinusitis With Nasal Polyps
Status:
Terminated
Trial end date:
2019-05-15
Target enrollment:
Participant gender:
Summary
The purpose of this randomized controlled double-blinded trial is to determine if the
addition of an oral antifungal to typical post-operative medical therapy can prevent or
reduce the incidence of recurrence of nasal polyps in fungal sensitive patients with chronic
rhinosinusitis with nasal polyps (CRSwNP).
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston